Jay M. Moyes, Chief Financial Officer at MYRIAD GENETICS INC (MYGN), sold 12,233 shares at $47.45 ($579K) on 2007-09-13, disclosed to the SEC on 2007-09-14.
Open-market sale of $579k MYGN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.14 | 1,581 | $75K | 12.9% |
| 2 | $47.15 | 919 | $43K | 7.5% |
| 3 | $47.16 | 200 | $9K | 1.6% |
| 4 | $47.18 | 300 | $14K | 2.4% |
| 5 | $47.19 | 800 | $38K | 6.5% |
| 6 | $47.20 | 500 |
| $24K |
| 4.1% |
| 7 | $47.21 | 300 | $14K | 2.4% |
| 8 | $47.35 | 248 | $12K | 2.0% |
| 9 | $47.37 | 400 | $19K | 3.3% |
| 10 | $47.38 | 300 | $14K | 2.5% |
| 11 | $47.39 | 600 | $28K | 4.9% |
| 12 | $47.40 | 681 | $32K | 5.6% |
| 13 | $47.42 | 300 | $14K | 2.5% |
| 14 | $47.43 | 1,900 | $90K | 15.6% |
| 15 | $47.45 | 3,204 | $152K | 26.3% |
| Total | $47.33 avg | 12,233 | $579K | 100% |
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |